Axim Daytime
Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Vivunt Pharma Llc
Human Otc Drug
NDC 82706-001Axim Daytime also known as Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride is a human otc drug labeled by 'Vivunt Pharma Llc'. National Drug Code (NDC) number for Axim Daytime is 82706-001. This drug is available in dosage form of Capsule, Liquid Filled. The names of the active, medicinal ingredients in Axim Daytime drug includes Acetaminophen - 325 mg/1 Dextromethorphan Hydrobromide - 10 mg/1 Phenylephrine Hydrochloride - 5 mg/1 . The currest status of Axim Daytime drug is Active.
Drug Information:
Drug NDC: | 82706-001 |
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
Proprietary Name: | Axim Daytime |
Also known as the trade name. It is the name of the product chosen by the labeler. |
Product Type: | Human Otc Drug |
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
Non Proprietary Name: | Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride |
Also known as the generic name, this is usually the active ingredient(s) of the product. |
Labeler Name: | Vivunt Pharma Llc |
Name of Company corresponding to the labeler code segment of the ProductNDC. |
Dosage Form: | Capsule, Liquid Filled |
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
Status: | Active |
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
Substance Name: | ACETAMINOPHEN - 325 mg/1 DEXTROMETHORPHAN HYDROBROMIDE - 10 mg/1 PHENYLEPHRINE HYDROCHLORIDE - 5 mg/1
|
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
Route Details: | ORAL
|
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: | OTC MONOGRAPH FINAL |
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Start Date: | 09 May, 2022 |
This is the date that the labeler indicates was the start of its marketing of the drug product. |
Marketing End Date: | 16 Jan, 2025 |
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
Application Number: | part341 |
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
Listing Expiration Date: | 31 Dec, 2023 |
This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name: | VIVUNT PHARMA LLC
|
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
RxCUI: | 1086997
|
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
Original Packager: | Yes
|
Whether or not the drug has been repackaged for distribution. |
UNII: | 362O9ITL9D 9D2RTI9KYH 04JA59TNSJ
|
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Pharmacologic Class: | Adrenergic alpha1-Agonists [MoA] Sigma-1 Agonist [EPC] Sigma-1 Receptor Agonists [MoA] Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC] Uncompetitive NMDA Receptor Antagonists [MoA] alpha-1 Adrenergic Agonist [EPC]
|
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. |
Packaging Information:
Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
---|
82706-001-01 | 3 BLISTER PACK in 1 CARTON (82706-001-01) / 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK | 09 May, 2022 | N/A | No |
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Active ingredients (in each softgel) purpose acetaminophen 325 mg pain reliever/fever reducer dextromethorphan hbr 10 mg cough suppressant phenylephrine hcl 5 mg nasal decongestant
Product Elements:
Axim daytime acetaminophen, dextromethorphan hydrobromide, phenylephrine hydrochloride propylparaben methylparaben glycerin fd&c yellow no. 6 fd&c red no. 40 gelatin polyethylene glycol 400 povidone k30 propylene glycol water sorbitol titanium dioxide acetaminophen acetaminophen dextromethorphan hydrobromide dextromethorphan phenylephrine hydrochloride phenylephrine axim
Indications and Usage:
Uses temporarily relieves common cold/flu symptoms: nasal congestion cough due to minor throat and bronchial irritation sore throat headache minor aches and pains fever
Warnings:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product allergy alert acetaminophen may cause severe skin reactions. symptoms may include: skin reddening blisters rash if a skin reaction occurs, stop use and seek medical help right away sore throat warning if sore throat is severe, lasts for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly. do not use with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric, or emotional conditions, or parkinson's disease), or for 2 weeks after stopping the maoi drug. i
Read more...f you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. if you have ever had an allergic reaction to this product or any of its ingredients ask a doctor before use if you have liver disease heart disease high blood pressure diabetes thyroid disease trouble urinating due to an enlarged prostate gland cough that occurs with too much phlegm (mucus) persistent or chronic cough as occurs with smoking, asthma, or emphysema ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin. when using this product do not exceed recommended dose stop use and ask a doctor if you get nervous, dizzy or sleepless pain or cough gets worse or lasts more than 7 days fever gets worse or lasts more than 3 days redness or swelling is present new symptoms occur cough comes back or occurs with rash or headache that lasts. these could be signs of a serious condition keep out of reach of children. if pregnant or breast-feeding ask a health professional before use. overdose warning in case of accidental overdose, seek professional assistance or contact a poison control center immediately.
Do Not Use:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if you take more than 4,000 mg of acetaminophen in 24 hours with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product allergy alert acetaminophen may cause severe skin reactions. symptoms may include: skin reddening blisters rash if a skin reaction occurs, stop use and seek medical help right away sore throat warning if sore throat is severe, lasts for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly. do not use with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist. if you are now taking a prescription monoamine oxidase inhibitor (maoi) (certain drugs for depression, psychiatric, or emotional conditions, or parkinson's disease), or for 2 weeks after stopping the maoi drug. if you do not know if your prescription drug contains an maoi, ask a doctor or pharmacist before taking this product. if you have ever had an allergic reaction to this product or any of its ingredients ask a doctor before use if you have liver disease heart disease high blood pressure diabetes thyroid disease trouble urinating due to an enlarged prostate gland cough that occurs with too much phlegm (mucus) persistent or chronic cough as occurs with smoking, asthma, or emphysema ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin. when using this product do not exceed recommended dose stop use and ask a doctor if you get nervous, dizzy or sleepless pain or cough gets worse or lasts more than 7 days fever gets worse or lasts more than 3 days redness or swelling is present new symptoms occur cough comes back or occurs with rash or headache that lasts. these could be signs of a serious condition keep out of reach of children. if pregnant or breast-feeding ask a health professional before use. overdose warning in case of accidental overdose, seek professional assistance or contact a poison control center immediately.
When Using:
When using this product do not exceed recommended dose
Dosage and Administration:
Directions take only as directed (see overdose warning) do not take more than 8 softgels in 24 hours. adults and children 12 years and over 2 softgels with water every 4 hours children 4 to under 12 years consult a doctor children under 4 years do not use
Stop Use:
Stop use and ask a doctor if you get nervous, dizzy or sleepless pain or cough gets worse or lasts more than 7 days fever gets worse or lasts more than 3 days redness or swelling is present new symptoms occur cough comes back or occurs with rash or headache that lasts. these could be signs of a serious condition
Package Label Principal Display Panel:
Principal display panel - axim daytime carton compare to vicks ® dayquil® cold&flu liquicaps® active ingredients* ndc 82706-001-01 axim - daytime cold&flu multi-symptom relief pain reliever fever reducer cough suppressant nasal decongestant non-drowsy acetaminophen , phenylephrine hcl, dextromethorphan hbr 24 softgels** **liquid-filled capsules *this product is not manufactured or distributed by the procter &gamble company, owner of the registered trademarks vicks® dayquil® and liquicaps®. axim day time